International Stem Cell Corporation Competitors and Similar CompaniesClear all
International Stem Cell Corporation's competitors and similar companies include ProtoKinetix, Cryo-Cell, Synthace and Alseres Pharmaceuticals.
 International Stem Cell Corporation International Stem Cell Corporation is a biotechnology company focused on therapeutic and research products. |  ProtoKinetix ProtoKinetix is a bio-technology company that provides medical researchers with a platform for enhancing cell survival and health, both in vitro and in vivo. |  Cryo-Cell Cryo-Cell International is a provider of cord blood banking and cord tissue storage services. |  Alseres Pharmaceuticals Alseres Pharmaceuticals, Inc. (ALSE) is focused on the development of diagnostic and therapeutic products for disorders in the central nervous system (CNS). | ||
Founding Date | Founding Date 2001 | Founding Date 1999 | Founding Date 1989 | Founding Date 2011 | Founding Date 1972 |
Type | Type Public | Type Public | Type Public | Type Private | Type Private |
Tags | |||||
Locations | Locations Carlsbad, US HQ Frederick, US Oceanside, US | Locations Marietta, US HQ | Locations Oldsmar, US HQ Santiago, CL San Pedro Sula, HN Guadalajara, MX Panamá City, PA North Miami Beach, US Caracas, VE | Locations London, GB HQ Boston, US Cambridge, US | Locations Newton, US HQ |
Employees | Employees 3919% decrease | Employees N/A | Employees 804% decrease | Employees 42 | Employees 4 |
Valuation ($) | Valuation ($) 640.4 k | Valuation ($) 3.9 m | Valuation ($) 47.9 m | Valuation ($) N/A | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) $9.1m (FY, 2025) | Revenue (est.) N/A | Revenue (est.) $31.6m (FY, 2025) | Revenue (est.) £1.3m (FY, 2022) | Revenue (est.) $473.7k (FY, 2013) |
Cost of goods | Cost of goods $4m (FY, 2025) | Cost of goods N/A | Cost of goods $7.4m (FY, 2025) | Cost of goods £942.1k (FY, 2022) | Cost of goods N/A |
Gross profit | Gross profit $5.1m (FY, 2025) | Gross profit N/A | Gross profit $24.2m (FY, 2025) | Gross profit £401k (FY, 2022) | Gross profit N/A |
Net income | Net income ($418k) (FY, 2025) | Net income ($364.2k) (FY, 2024) | Net income ($2.4m) (FY, 2025) | Net income (£8.9m) (FY, 2022) | Net income ($941.5k) (FY, 2013) |
Funding | |||||
Total funding raised | Total funding raised $ 7.5m | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 41.8m | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
ProtoKinetix
HQ
Marietta, US
ProtoKinetix is a bio-technology company that provides medical researchers with a platform for enhancing cell survival and health, both in vitro and in vivo.
View companyCryo-Cell
HQ
Oldsmar, US
Employees
80↓ 4% decrease
Cryo-Cell International is a provider of cord blood banking and cord tissue storage services.
View company
Synthace
HQ
London, GB
Employees
42
Synthace is a company that offers life sciences R&D cloud software for scientists.
View companyAlseres Pharmaceuticals
HQ
Newton, US
Employees
4
Alseres Pharmaceuticals, Inc. (ALSE) is focused on the development of diagnostic and therapeutic products for disorders in the central nervous system (CNS).
View company